Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-05-17T13:36:08.207Z Has data issue: false hasContentIssue false
  • English
  • Français

Expression of genes in the AKT signalling pathway in human oocytes from patients with polycystic ovaries

Published online by Cambridge University Press:  15 March 2023

N. Hafizi ,
B. Ozbakir  and
P. Tulay Open the ORCID record for P. Tulay [Opens in a new window]
N. Hafizi
Affiliation:
Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Cyprus
B. Ozbakir
Affiliation:
Near East University, Faculty of Medicine, Department of Obstetrics and Gynecology, Nicosia, Cyprus Near East University, DESAM Research Institute, Nicosia, Cyprus
P. Tulay*
Affiliation:
Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Cyprus Near East University, DESAM Research Institute, Nicosia, Cyprus
*
Author for correspondence: Pinar Tulay. Faculty of Medicine, Department of Medical Genetics, Near East University, DESAM Research Institute, Nicosia, Cyprus, Near East Boulevard, Nicosia North, Cyprus. E-mail: pinar.tulay@neu.edu.tr
Get access Rights & Permissions [Opens in a new window]

Summary

Polycystic ovary syndrome is an endocrine disorder commonly found among females of reproductive age. Different factors have been correlated with this syndrome, although the aetiology of the disease is still unrecognized with both environmental and hereditary factors leading to the progression. Hormonal effects of the AKT pathway have made it an interesting study unit for PCOS cases. The aim of this study was to investigate the expression patterns of genes involved in the AKT pathway, including IRS1, IRS2, AKT1 and AKT2. In total, 13 human oocytes were collected for this study at the meiosis II stage, in which seven of them were collected from individuals with polycystic ovaries and the rest formed the control group of individuals with no signs of polycystic ovaries. RNA was extracted from oocytes and then the RNA was converted into cDNA for the real-time PCR process. Expression levels of four genes in the AKT pathway, in addition to housekeeping gene (ACTB), were evaluated. Expression levels of each gene were quantified using real-time PCR and statistical analysis was performed. The results of this study showed that there was no significant correlation between the expression of genes in oocyte samples obtained from patients with polycystic ovaries and the control group. This study is the first to evaluate the expression levels of genes involved in the AKT pathway in human oocyte samples. Therefore, it provides crucial information to form the basis of further studies.

Keywords

AKT1AKT2Human oocytesIRS1IRS2PCOSPCR
Type
Research Article
Information
Zygote , Volume 31 , Issue 3 , June 2023 , pp. 237 - 239
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allemand, M. C., Irving, B. A., Asmann, Y. W., Klaus, K. A., Tatpati, L., Coddington, C. C. and Nair, K. S. (2009). Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes—A potential model for PCOS-related insulin resistance. PLOS ONE, 4(1), e4274. doi: 10.1371/journal.pone.0004274 CrossRefGoogle ScholarPubMed
Al-Omar, Z., Ozbakir, B. and Tulay, P. (2020). Differential expression of genes involved in steroidogenesis pathway in human oocytes obtained from patients with polycystic ovaries. Journal of Reproductive Immunology, 142, 103191. doi: 10.1016/j.jri.2020.103191 CrossRefGoogle ScholarPubMed
Crino, P. B., Nathanson, K. L. and Henske, E. P. (2006). The tuberous sclerosis complex. New England Journal of Medicine, 355(13), 1345–1356. doi: 10.1056/NEJMra055323 CrossRefGoogle ScholarPubMed
Duan, L., Jin, D., An, X., Zhang, Y., Zhao, S., Zhou, R., Duan, Y., Zhang, Y., Liu, X. and Lian, F. (2021). The potential effect of Rhizoma coptidis on polycystic ovary syndrome based on network pharmacology and molecular docking. Evidence-Based Complementary and Alternative Medicine: eCAM, 2021, 5577610. doi: 10.1155/2021/5577610 CrossRefGoogle ScholarPubMed
Dunaif, A. and Fauser, B. C. (2013). Renaming PCOS–A two-state solution. Journal of Clinical Endocrinology and Metabolism, 98(11), 4325–4328. doi: 10.1210/jc.2013-2040 CrossRefGoogle ScholarPubMed
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G. and Azziz, R. (2011). Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology, 7(4), 219–231. doi: 10.1038/nrendo.2010.217 CrossRefGoogle ScholarPubMed
Hanash, S. (2003). Disease proteomics. Nature, 422(6928), 226–232. doi: 10.1038/nature01514 CrossRefGoogle ScholarPubMed
Insler, V. and Lunenfeld, B. (1990). Polycystic ovarian disease: A challenge and controversy. Gynecological Endocrinology, 4(1), 51–70. doi: 10.3109/09513599009030691 CrossRefGoogle ScholarPubMed
Khan, M. J., Ullah, A. and Basit, S. (2019). Genetic basis of polycystic ovary syndrome (PCOS): Current perspectives. Application of Clinical Genetics, 12, 249–260. doi: 10.2147/TACG.S200341 CrossRefGoogle ScholarPubMed
Liu, C., Liu, L. H., Li, N., Xiu, A., Zhang, Z. and Ai, H. (2021). Efficacy of an Yinyanghuo (Herba Epimedii Brevicornus)-Xianmao (Rhizoma Curculiginis) drug pair in a rat model of polycystic ovary syndrome. Journal of Traditional Chinese Medicine, 41(4), 588–599. doi: 10.19852/j.cnki.jtcm.2021.03.011 Google Scholar
Qiao, H. Q. and Feng, J. (2010). Extra- and intra-ovarian factors in polycystic ovary syndrome: Impact on oocyte maturation and embryo developmental competence. Human Reproduction Update, 17(1), 17–33.10.1093/humupd/dmq032CrossRefGoogle ScholarPubMed
Wild, R. A. (2002). Long-term health consequences of PCOS. Human Reproduction Update, 8(3), 231–241. doi: 10.1093/humupd/8.3.231 CrossRefGoogle ScholarPubMed